Cytosolic P21Waf1/Cip1 Increases Cell Cycle Transit in Vascular Smooth Muscle Cells
Overview
Affiliations
The intracellular localization of signaling proteins is critical in directing their interactions with both upstream and downstream signaling cascade components. While initially described as a cyclin kinase inhibitor, p21Waf1/Cip1 has since been shown to have bimodal effects on cell cycle progression and cell proliferation, and evidence is emerging that intracellular localization of this protein plays a role in directing its signaling properties by dictating its interactions with downstream molecules. Since we have previously demonstrated a pro-apoptotic and cell cycle inhibitory effect of p21 attenuation after transfection of antisense p21 oligodeoxynucleotides (ODN) in several cell lines, we asked whether cytosolic p21 mediates a positive effect on vascular smooth muscle (VSM) cell cycle transit. We now show that transfection of a nuclear-localization signal deficient (DeltaNLS) p21 construct into VSM cells results in increased cytosolic levels of p21 and causes increased cell cycle transit as measured by [3H]thymidine incorporation. Thus, at least in VSM cells, cytosolic localization of p21 is a means by which this signaling protein transmits pro-mitogenic signals to the proteins responsible for G1/S transition. Furthermore, compartmentalization of p21 may help explain the biphasic nature of p21 in a variety of cell types and may lead to therapeutic advances directed at modulating pathologic cell growth in vascular diseases and cancer.
Mazzoldi E, Pasto A, Ceppelli E, Pilotto G, Barbieri V, Amadori A Front Oncol. 2019; 9:1211.
PMID: 31799185 PMC: 6874158. DOI: 10.3389/fonc.2019.01211.
Stapf M, Teichgraber U, Hilger I Int J Nanomedicine. 2017; 12:2793-2811.
PMID: 28435259 PMC: 5388224. DOI: 10.2147/IJN.S120969.
Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
Wettersten H, Landesman Y, Friedlander S, Shacham S, Kauffman M, Weiss R PLoS One. 2014; 9(12):e113867.
PMID: 25461627 PMC: 4252068. DOI: 10.1371/journal.pone.0113867.
A novel p21 attenuator which is structurally related to sorafenib.
Wettersten H, Hwang S, Li C, Shiu E, Wecksler A, Hammock B Cancer Biol Ther. 2013; 14(3):278-85.
PMID: 23298903 PMC: 3595311. DOI: 10.4161/cbt.23374.
Hukkelhoven E, Liu Y, Yeh N, Ciznadija D, Blain S, Koff A J Biol Chem. 2012; 287(46):38523-30.
PMID: 23007395 PMC: 3493897. DOI: 10.1074/jbc.M112.366542.